Please complete the CAPTCHA to continue
@duke.edu
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Marcus Cheek is listed as Director of Synthetic and Structural Biochemistry at EpiCypher, Inc. at EpiCypher, Inc., based in Raleigh-Durham-Chapel Hill Area, United States, United States. AeroLeads shows a work email signal at duke.edu and a matched LinkedIn profile for Marcus Cheek.
Marcus Cheek previously worked as Director of Synthetic and Structural Biochemistry (Chemistry) at Epicypher, Inc. and Lead Scientist, Bioanalytical Chemistry at Epicypher, Inc.. Marcus Cheek holds Doctor Of Philosophy (Phd), Chemistry, Biochemistry from Duke University.
This section adds company-level context without repeating Marcus Cheek's masked contact details.
AeroLeads found 1 current-domain work email signal for Marcus Cheek. Compare company email patterns before reaching out.
Ph.D.-level scientist with experience in analytical/organic/inorganic chemistry, proteomics, molecular structure elucidation, and protein synthesis. Currently working with startup and small companies to grow crucial multidisciplinary scientific divisions that share focused goals for obtaining external funding and breakout company growth.
Listed skills include Chemistry, Hplc, Organic Synthesis, Biochemistry, and 28 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Durham, North Carolina, US
Principal scientist in developing synthetic strategies to produce highly pure proteins with site-specific post-translational-modifications (PTMs). Developed post-synthetic protein purification and structural analysis methodologies for post-production support.Director of proteomics and mass spectroscopy: high resolution intact mass and top-down protein PTM.
Durham, North Carolina, US
(Winner of Best University Startup 2016, 114th United States Congress)Expression, purification, and characterization of recombinant histone proteins, octamers, and assembly of nucleosomes for commercial and academic use. Synthesis and purification of designer nucleosomes to provide highly pure and specific substrates for development of next generation.
Columbia, Missouri, US
Pittsburgh, PA, US
RNA aptamers and Click ChemistrySynthesized and purified azide/drug ligands that were “clicked” to 2′-modified DNA/RNA. Initially developed the idea of synthesizing versatile, clickable drug ligands for use in RNA aptamer-mediated drug delivery. Principle Investigators: Dr. Subha Das (CMU) and Dr. Rebekah White (Duke University)
Durham, North Carolina, US
Nucleotide Synthesis:Synthesized and purified α-P-borano nucleoside triphosphate (NTPαB) and diphosphate (NDPαB) analogs for use as Hepatitis C (HCV) RNA dependant RNA polymerase (RdRP) and human immunodeficiency virus reverse transcriptase (HIV-RT) inhibitors (Nucleic Acids Symposium Series (Oxf) 52(1); 81-82) Enzyme Kinetics:Successfully developed HCV.
Durham, North Carolina, US
Department: ChemistryPrincipal Investigator: Dr. Barbara Ramsay Shaw(see below)
Wilmington, NC, US
Wilmington, NC, US
Performed assay/impurity studies, using HPLC, including dissolution testing on client and AAI Pharma products in a GMP/GLP environment.
Formulated water and oil-based emulsions for clients. Developed organic synthesis procedures, from bench-top to bulk reactor that allowed for major cost reduction in raw materials. Developed methods for analyzing formulated products. Performed rheological studies on acrylic coatings for carpet and upholstery.
Researched safer and more effective methods to treat lumber, e.g. alkaline copper quaternary ammonium formulations (ACQ) to replace the more toxic copper chrome arsenic (CCA) treatment solutions. Assisted in the development of HPLC, ICP, FT-IR and wet chemistry methods pertaining to treatment solutions and treated wood, including analysis of treatment.
Quick answers generated from the profile data available on this page.
Marcus Cheek works for EpiCypher, Inc..
Marcus Cheek is listed as Director of Synthetic and Structural Biochemistry at EpiCypher, Inc. at EpiCypher, Inc..
AeroLeads has found 1 work email signal at @duke.edu for Marcus Cheek at EpiCypher, Inc..
Marcus Cheek is based in Raleigh-Durham-Chapel Hill Area, United States, United States while working with EpiCypher, Inc..
Marcus Cheek has worked for Epicypher, Inc., Abc Laboratories, Carnegie Mellon University, Duke University, and Ppd.
You can use AeroLeads to view verified contact signals for Marcus Cheek at EpiCypher, Inc., including work email, phone, and LinkedIn data when available.
Marcus Cheek holds Doctor Of Philosophy (Phd), Chemistry, Biochemistry from Duke University.
Marcus Cheek is listed with skills including Chemistry, Hplc, Organic Synthesis, Biochemistry, Molecular Biology, Analytical Chemistry, Mass Spectrometry, and Assay Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts